Stocklytics Platform
Asset logo for symbol IBIO
iBio
IBIO82
$2.41arrow_drop_up2.34%$0.05
Penny Stock
Asset logo for symbol IBIO
IBIO82

$2.41

arrow_drop_up2.34%

Performance History

Chart placeholder
Key Stats
Open$2.36
Prev. Close$2.36
EPS-4.03
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$22.09M
PE Ratio-
LOWHIGH
Day Range2.29
2.50
52 Week Range0.25
7.80
Ratios
Revenue-
EBITDA Margin %-
EPS-4.03

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About iBio (IBIO)

iBio Inc (IBIO) is a biotechnology company that focuses on the research, development, and commercialization of novel plant-based biopharmaceuticals. The company's proprietary technology platform, known as iBioLaunch™, uses plants to produce biologics such as vaccines, antibodies, and other therapeutic proteins. With this technology, iBio aims to revolutionize the way biopharmaceuticals are produced and improve access to affordable medicines.
One of the key advantages of iBio's plant-based biomanufacturing system is its scalability. Unlike traditional bioreactor-based production methods, iBio's system can be easily scaled up or down depending on demand. This flexibility allows iBio to quickly respond to market needs and accelerate the development and production of its products.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Martin B. Brenner D.V.M., Ph.D.
Headquarters
Bryan
Employees
105
Exchange
NYSE
add iBio  to watchlist

Keep an eye on iBio

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is iBio 's (IBIO) price per share?

The current price per share for iBio (IBIO) is $2.42. The stock has seen a price change of $0.06 recently, indicating a 2.34% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for iBio (IBIO)?

For iBio (IBIO), the 52-week high is $7.8, which is 222.94% from the current price. The 52-week low is $0.25, the current price is 866.12% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is iBio (IBIO) a growth stock?

iBio (IBIO) has shown an average price growth of -5.34% over the past three years. It has received a score of 89 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying iBio as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is iBio (IBIO) stock price performance year to date (YTD)?

As of the latest data, iBio (IBIO) has a year-to-date price change of 75.02%. Over the past month, the stock has experienced a price change of -5.65%. Over the last three months, the change has been 30.56%. Over the past six months, the figure is 15.56%. Looking at a longer horizon, the five-year price change stands at -50.71%.
help

Is iBio (IBIO) a profitable company?

iBio (IBIO) has a net income of -$24.91M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.95K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $225K. Operating income is noted at -$16.63M. Furthermore, the EBITDA is -$14.75M.
help

What is the market capitalization of iBio (IBIO)?

iBio (IBIO) has a market capitalization of $22.1M. The average daily trading volume is 2.36, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level